Bharat Biotech’s subsidiary Biovet unveils Biolumpivaxin, DIVA marker vaccine for lumpy skin disease

Join Pharma | Login

	Editorial


	THE FORCED SWIM TEST
	Tuesday, May 6, 2025
	The animal rights organization, People for the Ethical Treatment of Animals (PETA) has recently sent a letter to the Pharmacy Council of India (PCI) for discontinuing the Forced Swim Test (FST) in thousands of pharmacy institutions across the country.
	Past Editorial...

TODAY'S NEWS


15:30 [IST]	Bharat Biotech’s subsidiary Biovet unveils Biolumpivaxin, DIVA marker vaccine for lumpy skin disease
15:15 [IST]	API Holdings teams-up with IBM for its digital health technology stack with IBM Instana
15:00 [IST]	Newron Pharma gets US FDA nod for pivotal phase III ENIGMA-TRS programme with evenamide as add-on therapy in patients with treatment-resistant schizophrenia
14:15 [IST]	Hyderabad emerges as one of the top global centres of life sciences manufacturing: CBRE report
14:00 [IST]	KL Krems study shows that higher radiation doses in lung cancer treatment carry no added risk of inflammation – and may improve survival
13:30 [IST]	Abbott introduces TactiFlex sensor enabled ablation catheter in India, to treat abnormal heart rhythms

more news >>

TOP NEWS


08:00 [IST]	DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs
08:00 [IST]	BDCDA cautions on unauthorized channels and infiltration of counterfeit medicines into Karnataka
08:00 [IST]	Gujarat FDCA unveils strategic expansion with new drug testing lab in Ahmedabad: Dr H G Koshia
08:00 [IST]	Telangana DCA issues advisory to public & stakeholders to check QR code to block entry of counterfeits
08:00 [IST]	Lifesciences sector maximises adoption of advanced technologies to unlock new possibilities
08:00 [IST]	DTAB recommends prohibition of 34 antimicrobials for animal use

more news >>

YESTERDAY'S NEWS


16:30 [IST]	Emcutix collaborates with Canada-based Mantra Pharma to launch Ureaderm for Indian skin
15:15 [IST]	Trump signs landmark executive order slashing prescription drug prices between 50% & 90%
13:45 [IST]	Lupin launches tolvaptan tablets in the US with 180-day exclusivity
13:30 [IST]	Telangana DCA conducts special raids in pharmacies to verify QR codes on 300 formulation brands
12:40 [IST]	MedLern and Laerdal bring in advances on clinical skills building in Cytecare Hospitals
12:15 [IST]	NAB-CCM conducts webinar on “Tariffs vs. Temperature: Economic Policies Challenging the Cold Chain Industry”

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

USFDA Warning Letters Recently Posted For February 2025 Mephenamic Acid 250mg And Dicyclomine 20mg Tab Triamcinolone 40 Mg/ml Inj. Ondansetron 2mg/ml Tab Etoricoxib 120 Mg

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers